Characteristics of patients treated with carboplatin/cisplatin + etoposide VP16 first line chemotherapy.

Franco, Fernando; Carcereny, Enric; Guirado, Maria; Ortega, Ana L.; López-Castro, Rafael; Rodríguez-Abreu, Delvys; García-Campelo, Rosario; del Barco, Edel; Juan, Oscar; Aparisi, Francisco; González-Larriba, Jose L.; Domine, Manuel; Trigo, Jose M.; Cobo, Manuel; Cerezo, Sara; Calzas, Julia; Massutí, Bartomeu; Bosch-Barrera, Joaquim; Coves, Paola García; Domènech, Marta; Provencio, Mariano

doi:10.1371/journal.pone.0251761.s005

pone.0251761.s005.docx (14.7 kB)

Characteristics of patients treated with carboplatin/cisplatin + etoposide VP16 first line chemotherapy.

journal contribution

posted on 2021-06-02, 17:25 authored by Fernando Franco, Enric Carcereny, Maria Guirado, Ana L. Ortega, Rafael López-Castro, Delvys Rodríguez-Abreu, Rosario García-Campelo, Edel del Barco, Oscar Juan, Francisco Aparisi, Jose L. González-Larriba, Manuel Domine, Jose M. Trigo, Manuel Cobo, Sara Cerezo, Julia Calzas, Bartomeu Massutí, Joaquim Bosch-Barrera, Paola García Coves, Marta Domènech, Mariano Provencio

CNS, central nervous system; ECOG, Eastern Cooperative Oncology Group.

(DOCX)